Weed (BUDZ) EBIT Growth (1y) (2011 - 2026)
Weed (BUDZ) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 25.63% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.30% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -319.32% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -14.89% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 97.23% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 719.49% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.25% |
| 10 | Weed | 3.72 Mn | 3.72 Mn | - | 62.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.29% |
| Dec 31, 2025 | -470.27% |
| Sep 30, 2025 | 27.80% |
| Jun 30, 2025 | 35.12% |
| Mar 31, 2025 | -159.56% |
| Dec 31, 2024 | -289.24% |
| Sep 30, 2024 | 61.21% |
| Jun 30, 2024 | 7.18% |
| Mar 31, 2024 | 8.93% |
| Dec 31, 2023 | 88.66% |
| Sep 30, 2023 | 14.08% |
| Jun 30, 2023 | 61.66% |
| Mar 31, 2023 | 65.37% |
| Dec 31, 2022 | 37.39% |
| Sep 30, 2022 | -63.59% |
| Jun 30, 2022 | 66.27% |
| Mar 31, 2022 | 44.42% |
| Dec 31, 2021 | -125.04% |
| Sep 30, 2021 | 21.06% |
| Jun 30, 2021 | -117.01% |